science
Randomized Trial Shows Continuous Glucose Monitoring Superior to Self-Monitoring for Type 2 Diabetes Management
A randomized trial has demonstrated that continuous glucose monitoring outperforms traditional self-monitoring in regulating glucose levels for patients with Type 2 diabetes on basal insulin and other drug therapies. The study compared outcomes in glucose control among these patients. Better results were observed with continuous glucose monitoring.
ER
ncbi.nlm.nih.govAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
A randomized trial has demonstrated that continuous glucose monitoring is superior to self-monitoring for managing glucose regulation in patients with Type 2 diabetes who are on basal insulin and drug therapies, @EricTopol reported. The trial comparison focused on patients receiving basal insulin combined with other drug treatments for Type 2 diabetes.
Continuous glucose monitoring showed better outcomes in glucose control compared to traditional self-monitoring methods.
Transparency
1 source · single source
CorroborationModerate · 1 source
